Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction

US Patent 8541177 · Granted Sep 24, 2013

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →